our
science
Entheos Labs will be creating a pipeline of new chemical entities from a variety of psychoactive botanicals. One of our key goals is to unlock the therapeutic potential of these materials and compounds to address large unmet medical needs in mental healthcare and extend mental healthspan.
​
Entheos Labs will be using a world leading academic neuroimaging center to map for the first time how these newly studied neurplastogens interact with the brain.
There are multiple documented plant varieties with strong, unique neuroplasticity enhancing properties.
ET-01 is a synthetic derivate of a natural product, that was selected based on safety, tolerability, user-experience profile, and potent 5HT2A receptor agonism. ET-01 is being developed with a novel formulation and delivery method that we believe will generate an optimal target product profile.
We are investigating the medicinal potential of underexplored botanicals from indigenous cultures that have remained enigmatic in terms of active principles and underlying targets and mechanisms.